NZ501368A - 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions - Google Patents

3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions

Info

Publication number
NZ501368A
NZ501368A NZ501368A NZ50136897A NZ501368A NZ 501368 A NZ501368 A NZ 501368A NZ 501368 A NZ501368 A NZ 501368A NZ 50136897 A NZ50136897 A NZ 50136897A NZ 501368 A NZ501368 A NZ 501368A
Authority
NZ
New Zealand
Prior art keywords
dihydroxy
cholesten
3beta
pharmaceutical compositions
hmg
Prior art date
Application number
NZ501368A
Inventor
Name Supplied No
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9602100A external-priority patent/SE9602100D0/en
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of NZ501368A publication Critical patent/NZ501368A/en

Links

Abstract

The compound 3b-27-dihydroxy-5-cholestene-7-one or its HMG-CoA-active metabolite is useful for suppressing HMG-CoA reductase activity.
NZ501368A 1996-05-30 1997-05-29 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions NZ501368A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602100A SE9602100D0 (en) 1996-05-30 1996-05-30 New pharmaceuticals
NZ332776A NZ332776A (en) 1996-05-30 1997-05-29 Cytostatic cholesterol derivatives with an oxo group and a conjugated double bond in the steroid nucleus

Publications (1)

Publication Number Publication Date
NZ501368A true NZ501368A (en) 2000-07-28

Family

ID=26651991

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ501368A NZ501368A (en) 1996-05-30 1997-05-29 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions

Country Status (1)

Country Link
NZ (1) NZ501368A (en)

Similar Documents

Publication Publication Date Title
EP0529854A3 (en) Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors
HK1022105A1 (en) Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
AU2595697A (en) Compounds and compositions for delivering active agents
ATE320436T1 (en) DIMERIC PYRROLOBENZODIAZEPINES
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU4215800A (en) Dynamic server organization
AU6916894A (en) Refrigerant compositions including an acyclic fluoroether
EP1067130A4 (en) Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient
DK0630402T3 (en) New keto ester reductase, its preparation and its use for enzymatic redox reactions
AU9317298A (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
EP0462661A3 (en) Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
MY118381A (en) Statin-carboxyalkylether combinations
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
AU3630695A (en) Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
AU6500600A (en) Methods and compositions for determining enzymatic activity
AU5680900A (en) Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments
NZ501368A (en) 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions
AU5531798A (en) Pharmacologically active compounds and use
IL128771A0 (en) An agent for enhancing the activity of glutathione reductase containing troglitazone and use thereof
AU3459697A (en) Novel pyrimidine compounds and drug compositions
AU4578197A (en) Pharmaceutical compositions comprising hmg-coa reductase inhibitors, in particular fluvastatin
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
AU4302497A (en) Metalocarboxypeptidase inhibitors and derived molecules as antitumoural agents

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)